Gelonghui October 30th | Anhui Fengyuan Pharmaceutical (000153.SZ) released the third quarter report for 2024. In the first three quarters of 2024, the company achieved revenue of 3.261 billion yuan, a year-on-year increase of 1.16%; net income attributable to shareholders of the listed company was 0.147 billion yuan, a year-on-year increase of 3.40%; net income after deducting non-recurring gains and losses was 0.118 billion yuan, a year-on-year decrease of 9.64%; basic earnings per share 0.3169 yuan/share.
丰原药业(000153.SZ)：前三季度净利润1.47亿元，同比增长3.40%
Anhui Fengyuan Pharmaceutical (000153.SZ): The net income in the first three quarters was 0.147 billion yuan, a year-on-year increase of 3.40%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.